Foghorn Therapeutics, Inc. FHTX
NASDAQ · United States · Health Technology
$2.02-0.90 (-30.82%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.10 | -0.25 | +59.2% | $16.09M | +136.4% | +24.4%$4.88→$6.07 |
| Q1 2026 | 2026-05-07 | -0.29 | -0.28 | -3.6% | — | — | -5.1%$4.68→$4.44 |
| Q4 2025 | 2026-03-11 | -0.37 | -0.26 | -42.3% | — | — | -10.4%$5.49→$4.92 |
| Q3 2025 | 2025-11-05 | -0.25 | -0.31 | +19.4% | — | — | +13.3%$3.53→$4.00 |
| Q4 2024 | 2025-03-06 | -0.30 | -0.28 | -7.1% | — | — | — |
| Q1 2024 | 2024-05-06 | -0.59 | -0.59 | 0.0% | — | — | — |
| Q4 2023 | 2024-03-07 | -0.57 | -0.70 | +18.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.